Fundraising FoxSatellite Bio
Cambridge, US · Founded 2019 · 7 known investors
Find your way into Satellite Bio
Sign up to see every warm intro you have to Satellite Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Satellite Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Satellite Bio develops an off-the-shelf cell therapy that delivers functional liver cells (hepatocytes) into the body, where they engraft to restore liver function. The therapy targets patients with severe liver diseases and hepatic insufficiency who lack effective treatment options.
Founders & leadership
Satellite Bio was founded in 2019 by Christopher Chen.
Board
Investors · 7
How we know: aMoon's portfolio page · a partner's Signal profile · board seat on SEC Form D · Not right? Tell us
How we know: Catalio Capital Management, LP's portfolio page · Not right? Tell us
How we know: Lightspeed Venture Partners's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$101.5M disclosed across 2 rounds · 2020–2022
▶$82.5MraisedMar 2022 · 10 investors · BiotechnologyRule 506(b)
- Eileen McGuireDirector
- David LennonExecutive Officer, Director
- Christopher ChenDirector, Promoter
- Ling WongDirector
- Yair SchindelDirector
- Sangeeta BhatiaPromoter
- William YoungDirector
- Laura Lande-DinerExecutive Officer
- Diane MarcouExecutive Officer
- Offering amount
- $100M
- Amount sold
- $82.5M
- First sale
- Feb 2022
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$19MraisedNov 2020 · 7 investors · BiotechnologyRule 506(b)
- Ellie McGuireDirector
- Ling WongDirector
- Christopher ChenDirector, Promoter
- Sujata BhatiaDirector
- Sangeeta BhatiaPromoter
- Thomas LoweryExecutive Officer
- William YoungDirector
- Offering amount
- $19M
- Amount sold
- $19M
- First sale
- Nov 2020
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
3 people who came through Satellite Bio went on to found or lead other companies.
In the news
Frequently asked questions
- What does Satellite Bio do?
- Satellite Bio develops an off-the-shelf cell therapy that delivers functional liver cells (hepatocytes) into the body, where they engraft to restore liver function. The therapy targets patients with severe liver diseases and hepatic insufficiency who lack effective treatment options.
- Who founded Satellite Bio?
- Satellite Bio was founded by Christopher Chen in 2019.
- Who are Satellite Bio's investors?
- Satellite Bio's investors include Alumni Ventures, aMoon, Catalio Capital Management, LP, Lightspeed Venture Partners, Highbury Holdings, Polaris Partners, S32.
- How much funding has Satellite Bio raised?
- Satellite Bio has disclosed $101.5M raised across 2 rounds.
- Where is Satellite Bio headquartered?
- Satellite Bio is headquartered in Cambridge, US.